David T. Rubin to Tumor Necrosis Factor Ligand Superfamily Member 15
This is a "connection" page, showing publications David T. Rubin has written about Tumor Necrosis Factor Ligand Superfamily Member 15.
Connection Strength
0.246
-
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis. N Engl J Med. 2024 Sep 26; 391(12):1119-1129.
Score: 0.246
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.